Amgen Inc (AMG.DE)
Company Info
| ISIN | US0311621009 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Highlights
| Market Cap | €157.21B |
|---|---|
| EPS (TTM) | €5.24 |
| PE Ratio | 55.60 |
| PEG Ratio | 2.27 |
| Total Revenue (TTM) | €30.93B |
| Gross Profit (TTM) | €19.58B |
| EBITDA (TTM) | €10.92B |
| Year Range | €229.47 - €315.64 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AMG.DE vs. JNJ, AMG.DE vs. ABBV
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Amgen Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Amgen Inc had a return of 14.57% year-to-date (YTD) and 29.37% in the last 12 months. Over the past 10 years, Amgen Inc had an annualized return of 13.97%, outperforming the S&P 500 benchmark which had an annualized return of 10.67%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 14.57% | 15.38% |
| 1 month | -2.57% | 5.03% |
| 6 months | 18.44% | 6.71% |
| 1 year | 29.37% | 23.24% |
| 5 years (annualized) | 12.63% | 13.10% |
| 10 years (annualized) | 13.97% | 10.67% |
Monthly Returns
The table below presents the monthly returns of AMG.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 10.83% | -10.69% | 3.44% | -3.21% | 10.33% | 4.48% | 5.72% | -2.28% | 14.57% | ||||
| 2023 | -6.23% | -4.05% | 0.39% | -2.13% | -3.67% | -1.46% | 4.93% | 12.54% | 7.25% | -5.66% | 3.55% | 5.60% | 9.62% |
| 2022 | 0.65% | 0.32% | 8.84% | 1.98% | 6.79% | -1.92% | 4.03% | 0.41% | -3.14% | 17.07% | 0.40% | -9.41% | 26.47% |
| 2021 | 8.38% | -6.77% | 14.13% | -6.39% | 0.01% | 4.34% | -0.44% | -6.18% | -2.14% | -3.66% | 0.03% | 13.63% | 12.75% |
| 2020 | -11.65% | -4.81% | 4.32% | 14.07% | -5.80% | 3.40% | -0.70% | 3.59% | 1.87% | -13.86% | 0.11% | 0.58% | -11.41% |
| 2019 | -2.07% | 3.44% | 1.40% | -5.89% | -4.71% | 7.64% | 2.23% | 15.19% | -5.90% | 6.77% | 12.78% | 1.22% | 33.89% |
| 2018 | 1.63% | 1.79% | -7.87% | 4.76% | 6.67% | 3.02% | 5.07% | 4.00% | 3.61% | -4.54% | 7.29% | -8.18% | 16.81% |
| 2017 | 2.46% | 17.60% | -8.17% | -3.38% | -6.86% | 10.00% | -1.22% | 0.05% | 5.19% | -3.88% | -1.58% | 0.75% | 8.54% |
| 2016 | -9.30% | -0.91% | -2.04% | 3.83% | 3.95% | -3.78% | 12.61% | 0.78% | -3.13% | -12.45% | 6.61% | 1.85% | -4.45% |
| 2015 | 0.82% | 4.59% | 7.59% | -5.43% | 0.51% | -3.93% | 16.89% | -13.59% | -10.75% | 17.37% | 6.46% | -1.11% | 15.41% |
| 2014 | 6.22% | 3.66% | -2.20% | -9.83% | 7.03% | 2.46% | 9.75% | 11.38% | 5.56% | 16.92% | 2.20% | 0.45% | 64.95% |
| 2013 | -3.63% | 14.97% | 11.18% | 0.72% | 0.86% | -5.90% | 7.28% | 2.49% | -0.06% | 4.45% | -2.20% | -0.69% | 31.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of AMG.DE is 77, placing it in the top 23% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Amgen Inc (AMG.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Amgen Inc granted a 2.80% dividend yield in the last twelve months. The annual payout for that period amounted to €8.16 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €8.16 | €7.87 | €7.35 | €5.94 | €5.66 | €5.20 | €4.50 | €4.09 | €3.59 | €2.84 | €1.84 | €1.42 |
Dividend yield | 2.80% | 3.02% | 2.98% | 2.95% | 3.06% | 2.41% | 2.70% | 2.77% | 2.56% | 1.88% | 1.38% | 1.70% |
Monthly Dividends
The table displays the monthly dividend distributions for Amgen Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | €0.00 | €2.09 | €0.00 | €0.00 | €2.07 | €0.00 | €0.00 | €2.04 | €0.00 | €6.20 | |||
| 2023 | €0.00 | €1.98 | €0.00 | €0.00 | €1.96 | €0.00 | €0.00 | €1.96 | €0.00 | €0.00 | €1.96 | €0.00 | €7.87 |
| 2022 | €0.00 | €1.72 | €0.00 | €0.00 | €1.86 | €0.00 | €0.00 | €1.91 | €0.00 | €0.00 | €1.87 | €0.00 | €7.35 |
| 2021 | €0.00 | €1.45 | €0.00 | €0.00 | €1.45 | €0.00 | €0.00 | €1.49 | €0.00 | €0.00 | €1.55 | €0.00 | €5.94 |
| 2020 | €0.00 | €1.48 | €0.00 | €0.00 | €1.48 | €0.00 | €0.00 | €1.35 | €0.00 | €0.00 | €1.35 | €0.00 | €5.66 |
| 2019 | €0.00 | €1.28 | €0.00 | €0.00 | €1.30 | €0.00 | €0.00 | €1.30 | €0.00 | €0.00 | €1.32 | €0.00 | €5.20 |
| 2018 | €0.00 | €1.06 | €0.00 | €0.00 | €1.12 | €0.00 | €0.00 | €1.16 | €0.00 | €0.00 | €1.17 | €0.00 | €4.50 |
| 2017 | €0.00 | €1.09 | €0.00 | €0.00 | €1.05 | €0.00 | €0.00 | €0.98 | €0.00 | €0.00 | €0.98 | €0.00 | €4.09 |
| 2016 | €0.00 | €0.88 | €0.00 | €0.00 | €0.88 | €0.00 | €0.00 | €0.89 | €0.00 | €0.00 | €0.93 | €0.00 | €3.59 |
| 2015 | €0.00 | €0.70 | €0.00 | €0.00 | €0.70 | €0.00 | €0.00 | €0.71 | €0.00 | €0.00 | €0.73 | €0.00 | €2.84 |
| 2014 | €0.00 | €0.45 | €0.00 | €0.00 | €0.45 | €0.00 | €0.00 | €0.46 | €0.00 | €0.00 | €0.49 | €0.00 | €1.84 |
| 2013 | €0.35 | €0.00 | €0.00 | €0.36 | €0.00 | €0.00 | €0.35 | €0.00 | €0.00 | €0.35 | €0.00 | €1.42 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Amgen Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amgen Inc was 70.17%, occurring on Apr 4, 2008. Recovery took 1113 trading sessions.
The current Amgen Inc drawdown is 6.06%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -70.17% | Sep 12, 2000 | 1259 | Apr 4, 2008 | 1113 | Apr 3, 2013 | 2372 |
| -30.08% | Nov 10, 2022 | 142 | Jun 1, 2023 | 155 | Jan 9, 2024 | 297 |
| -25.98% | Aug 6, 2015 | 38 | Sep 28, 2015 | 347 | Feb 7, 2017 | 385 |
| -25.17% | Jan 25, 2000 | 35 | Mar 15, 2000 | 77 | Jul 10, 2000 | 112 |
| -23.4% | Dec 23, 2019 | 54 | Mar 12, 2020 | 30 | Apr 27, 2020 | 84 |
Volatility
Volatility Chart
The current Amgen Inc volatility is 4.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Amgen Inc compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for AMG.DE in comparison to other companies of the Drug Manufacturers - General industry. Currently, AMG.DE has a PE value of 55.6. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for AMG.DE in comparison to other companies of the Drug Manufacturers - General industry. Currently, AMG.DE has a PEG value of 2.3. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Amgen Inc.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |